Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Article Title: Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative neoplasms.
doi: 10.1016/j.jfma.2020.08.021
Figure Lengend Snippet: Figure 4 Effects of Ropeg on cytokine profiles. (A) Relative change in the percentages of levels of five cytokines over time in one particular patient. The plasma cytokine levels were measured with multiplex ELISA-based Q-plex Human Cyokine HS Screen Array (Quansys Biosciences), which contained more than a dozen of cytokines. Only cytokines with significantly altered levels after treatment are shown here. (B) The absolute values of plasma hepcidin levels over time in six PV patients. Human Hepcidin ELISA Kit (Cusabio Technology) was used for the quantification.
Article Snippet: The plasma cytokine levels were measured with multiplex ELISA-based Q-plex Human Cyokine HS Screen Array (Quansys Biosciences), which contained more than a dozen of cytokines.
Techniques: Clinical Proteomics, Multiplex Assay, Enzyme-linked Immunosorbent Assay